OCULAR THERAPEUTIX, INC Contracts & Agreements

Amendment No. 1 to Employee Stock Purchase Plan, effective October 4, 2023 (Filed With SEC on November 7, 2023)

Amendment No. 1 to Senior Subordinated Convertible Note, dated as of August 2, 2023, between the Registrant and the holders thereof (Filed With SEC on November 7, 2023)

Credit and Security Agreement, dated August 2, 2023, by and among Barings Finance LLC, as administrative agent, the Registrant, and the Lenders listed therein (Filed With SEC on November 7, 2023)

Amendment No. 2 to Fourth Amended and Restated Credit and Security Agreement, dated May 4, 2023, by and among MidCap Financial Trust, as administrative agent, the Registrant, and... (Filed With SEC on August 7, 2023)

2021 Stock Incentive Plan, as amended (Filed With SEC on August 7, 2023)

Third Amendment to Lease, by and between Ocular Therapeutix, Inc. and Cobalt PropCo 2020, LLC, dated June 30, 2023 (Filed With SEC on July 7, 2023)

Amendment No. 1 to Fourth Amended and Restated Credit and Security Agreement, dated March 31, 2023, by and among MidCap Financial Trust, as administrative agent, the Registrant,... (Filed With SEC on May 8, 2023)

Employment Agreement, by and between the Registrant and Christopher White, dated as of October 13, 2022 (Filed With SEC on March 6, 2023)

Employment Agreement, by and between the Registrant and Rabia Ozden-Gurses, dated as of September 28, 2022 (Filed With SEC on March 6, 2023)

Consulting Agreement by and between the Registrant and Dr. Jeffrey Heier, dated as of October 17, 2022 (Filed With SEC on March 6, 2023)

Consulting Agreement by and between the Registrant and Dr. Michael Goldstein, dated as of June 7, 2022 (Filed With SEC on August 8, 2022)

2021 Stock Incentive Plan, as amended (Filed With SEC on August 8, 2022)

Amendment No. 1 to License Agreement, by and between the Registrant and AffaMed Therapeutics (HK) Limited, dated as of October 28, 2021 (Filed With SEC on February 28, 2022)

Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan (Filed With SEC on February 28, 2022)

Form of Option Grant Agreement under 2021 Stock Incentive Plan (Filed With SEC on February 28, 2022)

Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on February 28, 2022)

Open Market Sale AgreementSM, dated as of August 9, 2021, by and between Ocular Therapeutix, Inc. and Jefferies LLC (Filed With SEC on August 9, 2021)

Fourth Amended and Restated Credit and Security Agreement dated June 4, 2021 by and among MidCap Financial Trust, as administrative agent, Ocular Therapeutix, Inc., and the... (Filed With SEC on June 4, 2021)

Supplement to License Agreement, by and between the Registrant and AffaMed Therapeutics Limited, dated as of January 18, 2021 (Filed With SEC on March 11, 2021)

Employment Agreement, by and between the Registrant and Philip Strassburger, dated August 28, 2020 (Filed With SEC on March 11, 2021)

Amendment to 2019 Inducement Stock Incentive Plan (Filed With SEC on March 11, 2021)

Underwriting Agreement, dated December 15, 2020, by and among Ocular Therapeutix, Inc. and Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters... (Filed With SEC on December 18, 2020)

License Agreement, by and between the Registrant and AffaMed Therapeutics Limited, dated October 29, 2020 (Filed With SEC on November 5, 2020)

Underwriting Agreement, dated October 13, 2020, by and among Ocular Therapeutix, Inc. and Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters... (Filed With SEC on October 16, 2020)

Underwriting Agreement, dated May 19, 2020, by and among Ocular Therapeutix, Inc. and Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named... (Filed With SEC on May 22, 2020)

Amendment to Collaboration, Option and License Agreement, by and between the Company and Regeneron, dated May 8, 2020 (Filed With SEC on May 14, 2020)

Employment Agreement, by and between the Registrant and Patricia Kitchen, dated as April 21, 2019 (Filed With SEC on May 8, 2020)

Separation and Release of Claims Agreement by and between the Registrant and Daniel Bollag, dated December 2, 2019 (Filed With SEC on March 12, 2020)

Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)

Form of Inducement Nonstatutory Stock Option Agreement (Filed With SEC on November 12, 2019)

2019 Inducement Stock Incentive Plan (Filed With SEC on November 12, 2019)

Consulting Agreement by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of August 2, 2019 (Filed With SEC on August 7, 2019)

Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of August 2, 2019 (Filed With SEC on August 7, 2019)

Second Amendment to Third Amended and Restated Credit and Security Agreement, by and among Ocular Therapeutix, Inc., MidCap Financial Trust as administrative agent, and the... (Filed With SEC on August 7, 2019)

Consulting Agreement by and between Ocular Therapeutix, Inc. and Dr. Amarpreet S. Sawhney, dated as of May 29, 2019 (Filed With SEC on May 30, 2019)

Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Dr. Amarpreet S. Sawhney, dated as of May 29, 2019 (Filed With SEC on May 30, 2019)

Sublease, dated as of April 4, 2019, by and among Ocular Therapeutix, Inc. and Holcim (US) Inc (Filed With SEC on May 10, 2019)

Open Market Sales AgreementSM, dated as of April 5, 2019, by and between Ocular Therapeutix, Inc. and Jefferies LLC (Filed With SEC on April 5, 2019)

Registration Rights Agreement, dated as of March 1, 2019, by and among the Registrant and the Purchasers identified therein (Filed With SEC on March 7, 2019)

Note Purchase Agreement (including Form of Senior Subordinated Convertible Note), dated as of February 21, 2019, by and among Ocular Therapeutix, Inc. and the Purchasers listed... (Filed With SEC on February 22, 2019)

Form of Registration Rights Agreement by and among Ocular Therapeutix, Inc. and the Purchasers listed therein (Filed With SEC on February 22, 2019)

First Amendment to Third Amended and Restated Credit and Security Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as... (Filed With SEC on February 22, 2019)

Subordination Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as administrative agent, and the Lenders listed therein (Filed With SEC on February 22, 2019)

Third Amended and Restated Credit and Security Agreement dated December 21, 2018 by and among MidCap Financial Trust, as administrative agent, Ocular Therapeutix, Inc., and the... (Filed With SEC on December 28, 2018)

Second Amended and Restated License Agreement, dated September 13, 2018, by and between Ocular Therapeutix, Inc. and Incept LLC (Filed With SEC on September 19, 2018)

Second Amendment to Employment Agreement, by and between Ocular Therapeutix, Inc. and Amarpreet S. Sawhney, dated August 6, 2018 (Filed With SEC on August 7, 2018)

Employment Agreement, by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of January 5, 2018 (Filed With SEC on March 8, 2018)

Employment Agreement, by and between Ocular Therapeutix, Inc. and Daniel Bollag, dated as of July 31, 2017 (Filed With SEC on March 8, 2018)

Employment Agreement, by and between Ocular Therapeutix, Inc. and Michael Goldstein, dated as of September 25, 2017 (Filed With SEC on March 8, 2018)

Underwriting Agreement, dated January 25, 2018, by and between Ocular Therapeutix, Inc. and Piper Jaffray & Co (Filed With SEC on January 25, 2018)

Second Amendment to Lease, by and between Ocular Therapeutix, Inc. and CCC Investors LLC, dated October 10, 2017 (Filed With SEC on October 16, 2017)

Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and James Fortune, dated as of October 13, 2017 (Filed With SEC on October 13, 2017)

Employment Agreement, by and between Ocular Therapeutix, Inc. and Donald Notman, dated as of September 25, 2017 (Filed With SEC on September 25, 2017)

OCULAR THERAPEUTIX, INC. CONSULTING AGREEMENT (Filed With SEC on August 3, 2017)

TRANSITION, SEPARATION AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on August 3, 2017)

OCULAR THERAPEUTIX, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on June 22, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on June 22, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on June 22, 2017)

SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (Filed With SEC on May 5, 2017)

3,571,429 Shares OCULAR THERAPEUTIX, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on January 25, 2017)

OCULAR THERAPEUTIX, INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 30, 2016)

Confidential Materials omitted and filed separately with the Securties and Exchange Commission. Double asterisks denote omissions (Filed With SEC on November 9, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)

FIRSTAMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (Filed With SEC on August 9, 2016)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LEASE WS NV 15 CROSBY DRIVE,LLC, Landlord, and... (Filed With SEC on August 9, 2016)

AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (Filed With SEC on December 9, 2015)

[] Shares OCULAR THERAPEUTIX, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on June 2, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2014)

[] Shares OCULAR THERAPEUTIX, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on July 11, 2014)

OCULAR THERAPEUTIX, INC. 2014STOCK INCENTIVE PLAN (Filed With SEC on July 11, 2014)

OCULAR THERAPEUTIX, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on July 11, 2014)

OCULAR THERAPEUTIX, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on July 11, 2014)

OCULAR THERAPEUTIX, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on July 11, 2014)

OCULAR THERAPEUTIX, INC. 2014EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 11, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2014)

LEASE RAR2-CROSBY CORPORATECENTER QRS, INC., a Maryland corporation Landlord, and I-THERAPEUTIX, INC., a Delawarecorporation Tenant TABLE OF CONTENTS (Filed With SEC on June 20, 2014)

OCULAR THERAPEUTIX, INC. FOURTHAMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT May 31, 2013 TABLE OF CONTENTS (Filed With SEC on June 20, 2014)

OCULAR THERAPEUTIX, INC. 2006 STOCK INCENTIVE PLAN, AS AMENDED (Filed With SEC on June 20, 2014)

OCULAR THERAPEUTIX, INC. 2006 STOCK INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on June 20, 2014)

STOCK REPURCHASE AGREEMENT (Filed With SEC on June 20, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on June 20, 2014)

INDEMNIFICATION AGREEMENT (Filed With SEC on June 20, 2014)

CREDITAND SECURITY AGREEMENT (Filed With SEC on June 20, 2014)

Category

Industry

Companies

Contracts

OCULAR THERAPEUTIX, INC Contracts & Agreements